CDC Awards Nearly $500,000 to the Multiple Myeloma Research Foundation for Blood Cancer Education Program

New Canaan, Conn. — September 7, 2004
Funds to Support Education Efforts for Both Physicians and Patients

The Multiple Myeloma Research Foundation (MMRF) has been awarded $497,560, in year one of a potential three-year program, from the Centers for Disease Control and Prevention (CDC) to support its blood cancer education program efforts. The funds will go directly to support the MMRF Nationwide Patient and Provider Education and Outreach Program to increase awareness of treatment options and clinical trials among physicians, to improve the reach and effectiveness of patient education strategies, and to increase the awareness of multiple myeloma patient resources among patients and providers. The program will be fully funded through this Cooperative Agreement with the CDC.

This award is part of the CDC's "National Health Organization Strategies to Provide Information and Education for Patients, their Family Members, Friends and Care Givers with Respect to Hematologic Cancers" program, which directly resulted from Senator Kay Bailey Hutchison's (R-TX) commitment to increase research funding for blood cancer education. Senator Hutchison, whose brother suffers from multiple myeloma, has been working for several years to pass legislation that would increase medical research and education funding to help find a cure for fatal blood cancers such as multiple myeloma. In March 2004, her efforts secured $4.9 million through the Geraldine Ferraro Blood Cancer Education Program to bring vital education services to blood cancer patients and their families. This award was made possible through that program.

The Geraldine Ferraro Blood Cancer Education Program was part of Senator Hutchison's bill, the Hematological Cancer Research Investment and Education Act (S. 1094), which President Bush signed on May 14, 2002. The MMRF worked closely with Senator Hutchison to introduce this legislation, and continues to work with Senator Hutchison and the Honorable Geraldine Ferraro to advance public policy initiatives that accelerate and intensify efforts to bring new therapies and high quality care to patients everywhere with blood cancers.

"We are so pleased to have the CDC support the tremendous need to educate both patients and physicians about multiple myeloma," says MMRF Program Director Anne Quinn Young. "Because multiple myeloma affects fewer than 50,000 Americans per year, many physicians are not aware of the most up-to-date treatment options or clinical trials for these patients. When physicians are not educated about the latest research, patients are likely to receive inferior care."

The MMRF was founded in 1998 by twin sisters Karen Andrews and Kathy Giusti to help accelerate the search for a cure for multiple myeloma. The MMRF is the number-one private funder of myeloma-specific research, raising more than $50 million to fund 51 institutions worldwide. The MMRF is the world's only non-profit organization to have the earned a four-star rating from Charity Navigator, approval by the Better Business Bureau's Wise Giving Alliance Standards for Charity Accountability, and approval by the National Cancer Institute for its grants-making process. To learn more about the MMRF, visit www.themmrf.org. For more information, please contact Rosalind D'Eugenio at Environics Communications at 203-325-8772, 13 or rdeugenio@environics-usa.com.

For information, contact:
Anne Quinn Young, MMRF, 203-652-0212, quinnyoung@www.themmrf.org